Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Miels said that the pharmaceutical company has since “rebuilt” its business in China....
...Novartis notched a 10 per cent increase in sales in 2023 as strong performance for its heart and arthritis medicines helped Europe’s second-largest pharmaceuticals company beat its guidance for the year....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Where doubts creep in is how Novartis will replace lost sales from 2027....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...focused Novartis”....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Big share price moves in Europe this morning include Swiss pharmaceutical group Novartis, London-listed betting group Entain and French maker of rail infrastructure Alstom....
Admonitions about staff trading in their employer’s shares may now need to be broadened
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...Hassabis stated the goal days after announcing Isomorphic Lab’s first two pharmaceutical partnerships with Eli Lilly and Novartis, which came to a combined value of up to $3bn, in deals set to transform...
...The deal comes as pharmaceutical companies gather in San Francisco for an annual industry conference, with GSK rivals Johnson & Johnson, Novartis and Merck announcing acquisitions on Monday....
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...Shares in Novartis were up just over 3 per cent in early trading on Tuesday, but have languished this year....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
..., and Merck and Novartis signing smaller deals on Monday....
...Swiss pharmaceutical giant Novartis has launched a $15bn share buyback programme after raising its outlook for the year on the back of strong sales....
...was so appalling, no one else bothered to invest capital to enter that space because it wasn’t an attractive market,” says Richard Saynor, chief executive of Sandoz, a generics manufacturer spun-out from Novartis...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
International Edition